COL1A2 and urinary bladder carcinoma: Collectively, our integrative multi-omics and experimental findings position COL1A2 as a vital molecular driver of NMIBC-to-MIBC progression via ECM pathway activation, underscoring its central role in bladder cancer stage evolution.